Canada's biotechnology sector has expanded rapidly in the last decade in terms of industry-wide revenues, the launch of new companies and in the continuous diversification of its products.  Canada continues to hold its position as one of the top five countries active in biotechnology.  Our high international standing in biotechnology is a reflection of leading-edge research, a proven entrepeneurial approach that emphasizes clusters and partnerships, and a strong financing and venture capital base for the industry.

CNSX is responding to the needs of our emerging Biotechnology companies with a full complement of exchange services to assist them in achieving their growth objectives.

CNSX stocks in the Biotechnology sector include: